FOSUN INTL(HK:00656) GUOTAI HAITONG SECURITIES·2026-03-10 02:55Investment Rating - The report assigns an "Accumulate" rating to Fosun International, with a target price of HKD 7.24 per share, based on a NAV valuation of HKD 18.1 per share [8]. Core Insights - The valuation is currently low, with a clear strategic focus on core sectors, continuous improvement in asset quality, and a steady increase in credit ratings. The company's operational fundamentals are improving, with expected earnings growth and upward performance potential [2]. Financial Summary - Total revenue projections (in million RMB) for 2024A to 2028E are as follows: - 2024A: 192,142 (-3.06%) - 2025E: 170,932 (-11.04%) - 2026E: 180,434 (+5.56%) - 2027E: 191,091 (+5.91%) - 2028E: 203,521 (+6.50%) [4] - Net profit projections show a significant turnaround from a loss of 4.35 billion in 2024A to a profit of 4.13 billion in 2028E, indicating a recovery trajectory [4]. Company Overview - Fosun International is positioned as a global family consumption industry group, focusing on health, happiness, wealth, and intelligent manufacturing sectors. The company aims to enhance family life through a comprehensive service offering [12][21]. - The company has undergone a strategic "slimming down" process, divesting non-core assets and focusing on its main business areas, which has led to improved asset quality and financial leverage [8][26]. Strategic Focus - The company is concentrating on four main sectors: health, happiness, wealth, and intelligent manufacturing. Each sector is designed to provide comprehensive services and products to global families [21][22]. - The health sector is focused on pharmaceuticals, diagnostics, and health services, while the happiness sector emphasizes leisure, cultural consumption, and fashion brands. The wealth sector is centered on insurance and asset management, and the intelligent manufacturing sector targets strategic resources and new materials [21][22]. Performance Outlook - The company is expected to experience a rebound in profitability, with improved operational quality driving valuation increases. The credit rating has been upgraded, and cost reductions are anticipated to enhance profit margins [4][8]. - The health sector's revenue is projected to remain stable, with significant contributions from innovative drug developments and medical services, while the happiness sector faces challenges due to market conditions [35][41].